❗️SURMOUNT-4
Maintenance effects of Tirzepatide vs placebo ❗️ #EASD2023
🔸great weight loss with percentage weight loss>25% in over half on treatment
🔹expected weight regain off treatment
🔸impressive BP reduction
🔹unusual to see the maintenance then rise in ALT in placebo…

Clinical inertia is a major obstacle in #type2diabetes

Guidelines state if a pt fails to reach glucose goal on 1 med in 3 months, a 2nd should be added 💊

But it takes 1.6 years for a 2nd medication to be added in the real world! 👀This translates to poorer outcomes

#EASD2023

Visit us! PCDE Booth #EASD2023

#EASD2023 was fab!

How it started👉🏽Presenting “New treatment approaches & clinical strategies for improving outcomes for people with advanced diabetic retinopathy”

How it ended👉🏽CoChair with Erika “Looking to future-risks & benefits of glycaemic control in diabetic retinopathy”

Timo Otonkoski - functional stem cell derived islets no longer a dream, now a reality! #EASD2023

AiDAPT trial RCT T1 pregnancy publication now out. Prof Murphy - benefits of automated insulin delivery throughout pregnancy, TiR. Also look out for paper describing experiences of study participants, v powerful. HCL sould be offered to all T1D preg women. #EASD2023

Dr. B worked in a diabetic wound clinic for many years. He knows firsthand the results of following the high-carb guidelines that are set by the diabetes industry and professional associations. #EASD2023

🗣️Hace apenas 3 días finalizó el Congreso Europeo de Diabetes #EASD2023 …

👉🏻 Después de muchos años sin novedades en los criterios dignósticos de #diabetes …
El gran Jakko Toumilehto trajo un planteo #disruptivo :💥

🆕Utilizar la glucosa posprandial a la hora de la sobrecarga!

🌟 Exciting news from EASD 2023 in Hamburg! Mumbai Hall proudly represents India among global cities. Dr. Banshi Saboo, Southeast Asia IDF Chair, and Padmashri awardee Dr. Shashank Joshi grace us with their wisdom. An honor beyond words! 🇮🇳
#EASD2023
#RIMS
#ProudMoment

Third consecutive study (T2NOW study with saxagliptin) failed to show any benefit with DPP4i in adolescents (10-17 years) T2D. Earlier Sitagliptin and Linagliptin study (DINAMO) also failed to show any benefit in the same age group. #EASD2023 . Why DPP4i doesn’t work in this age?

Surmount 4 gave patients with #obesity #tirzepatide x 36 weeks before randomizing to continued tirzepatide vs placebo EASD #easdrme
*over 50% achieving >25% reduction??!! 🤩🤯 #EASD2023

I've been following #EASD2023 entirely through social media this week and this is what I've taken away (I have #T1D so more focused on that, this isn't meant to summarise the whole conference!). Thanks to #dedoc for sharing everything! I'll write up more soon! #gbdoc

Real-world OmniPod 5 data from the USA being presented by Emma Wilmot - my first take home: the link from PDM to cloud ensure completeness of reporting for real-world evidence building (IMO also a good tool for clinic and reducing inequality!). #EASD2023

I wrote a blog post about my experience attending and presenting at #EASD2023 this month!

Read it here: ieureka.blogs.bristol.ac.uk/2023/10/25/eas…

Excellent talk by Prof Mohammed Hasnenain at the #EASD2023 on the DIA-RAMADAN study. Reassuring results for the use of #SGLT2i and #sulphonylurea in the fasting #muslim patient

Kesin bilgi yayalım 😎
Demli bir çay içilmesi yetişkinlerde Tip 2 Diyabet gelişimini azaltabilirmiş👍🏻😂

Çay seviyorsak sebebi var demiştik🫶🏻

#Çay
#Çarşamba
#EASD2023

Delighted to see this out today, coinciding with the #EASD2023 Precision Medicine in Diabetes Session

A massive effort from >200 scientists to define gaps and opportunities for the clinical translation of precision diabetes medicine

nature.com/articles/s4159…

Key takeaways below:

Moving #dedoc session at #EASD2023 hearing from Helga Nefdt on how she felt ‘deeply ashamed’ following her diagnosis of gestational diabetes.

Tackling the stigma associated with all forms of diabetes, correcting misinformation and amplifying voices is so important.

أتشرف بالمشاركة كمتحدث في مؤتمر الرابطة الأوروبية لدراسة أمراض السكري بألمانيا EASD #EASD2023

❇️ ٣ محاضرات عن تقنيات السكري ومضخات الانسولين ودورها في:

✔️تحسين رعاية السكري
✔️تحسين جودة الحياة
✔️تسهيل صيام شهر رمضان لمصابي السكري النوع الأول في السعودية والشرق الأوسط🇸🇦🇸🇦

New video. I Interviewed Alex Moussa, SVP at Dexcom about Dexcom updates #EASD2023 . We covered details and countries related to the Control IQ and Dexcom G7 announcement, Dexcom One and the environment! As more people use CGM, this is key. Enjoy and Share!
youtu.be/Ya9OU-UrT-0